An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
Completed
Centocor BV
Phase 2
2003-11-01
Multicenter, randomized, double-blind, placebo-controlled, 5-arm, dose-ranging study to
assess the efficacy of subcutaneous injections of Golimumab (CNTO 148), 50 or 100 mg, at
either 2- or 4- week intervals in subjects with active RA despite MTX therapy.
An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis
Completed
Centocor, Inc.
Phase 2
2003-11-01
Multicenter, randomized, double-blind, placebo-controlled, 5-arm, dose-ranging study to
assess the efficacy of subcutaneous injections of Golimumab (CNTO 148), 50 or 100 mg, at
either 2- or 4- week intervals in subjects with active RA despite MTX therapy.
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
Completed
Schering-Plough
Phase 3
2005-12-01
The purpose of this study is to evaluate the efficacy and safety of golimumab, alone or in
combination with methotrexate, as compared to methotrexate alone in rheumatoid arthritis
subjects who have not been previously treated with methotrexate.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.